微生物-免疫-代谢轴在儿童肥胖相关性哮喘中的研究进展

肖舒畅, 张方

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (9) : 1143-1149.

PDF(755 KB)
HTML
PDF(755 KB)
HTML
中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (9) : 1143-1149. DOI: 10.7499/j.issn.1008-8830.2601132
综述

微生物-免疫-代谢轴在儿童肥胖相关性哮喘中的研究进展

作者信息 +

Research progress on the microbiota-immune-metabolism axis in childhood obesity-related asthma

Author information +
文章历史 +

摘要

儿童哮喘及肥胖的患病率均在逐年攀升,肥胖相关哮喘成为独特的哮喘临床表型,儿童肥胖不仅是哮喘的诱发因素,更是驱动疾病进展及影响疗效的关键病理生理环节。肠道菌群及其代谢产物的组成在肥胖状态下发生改变,通过肠-肺轴激活肺部免疫,而肥胖引起的全身性慢性炎症及代谢紊乱与肺部免疫失衡、气道重塑及气道高反应性等密切相关,共同构成微生物-免疫-代谢轴。该文综述了肥胖通过微生物-免疫-代谢轴影响儿童哮喘的潜在机制,旨在探索和深化对于肥胖影响儿童哮喘机制的认识,为临床干预及转化提供研究思路及靶点。

Abstract

Childhood asthma and obesity are rising in prevalence, and obesity-related asthma has emerged as a distinct clinical phenotype. In children, obesity is not only a trigger for asthma but also a key pathophysiological driver of disease progression and a modifier of treatment response. In obesity, shifts in the composition of the gut microbiota and its metabolites can activate pulmonary immunity through the gut-lung axis, while obesity-induced chronic systemic inflammation and metabolic dysregulation are closely linked to pulmonary immune imbalance, airway remodeling, and airway hyperresponsiveness. Together, these processes constitute the microbiota-immune-metabolism axis. This review summarizes potential mechanisms by which obesity influences childhood asthma via this axis and aims to deepen mechanistic understanding and provide research directions and targets for clinical intervention and translation.

关键词

哮喘 / 肥胖 / 微生物-免疫-代谢轴 / 肠道菌群 / 短链脂肪酸 / 儿童

Key words

Asthma / Obesity / Microbiota-immune-metabolism axis / Gut microbiota / Short-chain fatty acid / Child

引用本文

导出引用
肖舒畅, 张方. 微生物-免疫-代谢轴在儿童肥胖相关性哮喘中的研究进展[J]. 中国当代儿科杂志. 2026, 28(9): 1143-1149 https://doi.org/10.7499/j.issn.1008-8830.2601132
Shu-Chang XIAO, Fang ZHANG. Research progress on the microbiota-immune-metabolism axis in childhood obesity-related asthma[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(9): 1143-1149 https://doi.org/10.7499/j.issn.1008-8830.2601132

参考文献

[1]
中华医学会儿科学分会呼吸学组, 中华儿科杂志编辑委员会, 中国医药教育协会儿科专业委员会. 儿童支气管哮喘诊断与防治指南(2025)[J]. 中华儿科杂志, 2025, 63(4): 324-337. DOI: 10.3760/cma.j.cn112140-20250124-00074 .
[2]
中华医学会呼吸病学分会. 支气管哮喘防治指南(2024年版)[J]. 中华结核和呼吸杂志, 2025, 48(3): 208-248. DOI: 10.3760/cma.j.cn112147-20241013-00601 .
[3]
Zhou W, Tang J. Prevalence and risk factors for childhood asthma: a systematic review and meta-analysis[J]. BMC Pediatr, 2025, 25(1): 50. PMCID: PMC11744885. DOI: 10.1186/s12887-025-05409-x .
[4]
伊娜, 刘婷婷, 周宇畅, 等. 1990—2019年中国儿童青少年哮喘疾病负担分析[J]. 中华流行病学杂志, 2023, 44(2): 235-242. DOI: 10.3760/cma.j.cn112338-20220526-00469 .
[5]
臧潇, 邹言峥, 陶璐秋, 等. 中国儿童1990—2021年哮喘疾病负担变化及未来趋势预测[J]. 中国学校卫生, 2025, 46(4): 573-578. DOI: 10.16835/j.cnki.1000-9817.2025124 .
[6]
Hampl SE, Hassink SG, Skinner AC, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity[J]. Pediatrics, 2023, 151(2): e2022060640. DOI: 10.1542/peds.2022-060640 .
[7]
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2 416 population-based measurement studies in 128 9 million children, adolescents, and adults[J]. Lancet, 2017, 390(10113): 2627-2642. PMCID: PMC5735219. DOI: 10.1016/S0140-6736(17)32129-3 .
[8]
Deng X, Ma J, Yuan Y, et al. Association between overweight or obesity and the risk for childhood asthma and wheeze: an updated meta-analysis on 18 articles and 73 252 children[J]. Pediatr Obes, 2019, 14(9): e12532. DOI: 10.1111/ijpo.12532 .
[9]
Song XL, Liang J, Lin SZ, et al. Gut-lung axis and asthma: a historical review on mechanism and future perspective[J]. Clin Transl Allergy, 2024, 14(5): e12356. PMCID: PMC11060082. DOI: 10.1002/clt2.12356 .
[10]
Škrgat S, Harlander M, Janić M. Obesity and insulin resistance in asthma pathogenesis and clinical outcomes[J]. Biomedicines, 2024, 12(1): 173. PMCID: PMC10813771. DOI: 10.3390/biomedicines12010173 .
[11]
Balasundaram P, Avulakunta ID. Human Growth and Development[M]//StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2026.
[12]
Global Initiative for Asthma. 2023 GINA report, global strategy for asthma management and prevention[R/OL]. [2026-02-28].
[13]
Abu Zahra M, Pessin J, Rastogi D. A clinician's guide to effects of obesity on childhood asthma and into adulthood[J]. Expert Rev Respir Med, 2024, 18(10): 759-775. PMCID: PMC11473229. DOI: 10.1080/17476348.2024.2403500 .
[14]
Mazzotta C, Barkai L. Obesity and asthma in children: coexistence or pathophysiological connections?[J]. Biomedicines, 2025, 13(5): 1114. PMCID: PMC12109551. DOI: 10.3390/biomedicines13051114 .
[15]
Kim HY, Lee HJ, Chang YJ, et al. Interleukin-17: producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity[J]. Nat Med, 2014, 20(1): 54-61. PMCID: PMC3912313. DOI: 10.1038/nm.3423 .
[16]
Thompson CA, Eslick SR, Berthon BS, et al. Asthma medication use in obese and healthy weight asthma: systematic review/meta-analysis[J]. Eur Respir J, 2021, 57(3): 2000612. DOI: 10.1183/13993003.00612-2020 .
[17]
Fujimura KE, Sitarik AR, Havstad S, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation[J]. Nat Med, 2016, 22(10): 1187-1191. PMCID: PMC5053876. DOI: 10.1038/nm.4176 .
[18]
Depner M, Taft DH, Kirjavainen PV, et al. Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma[J]. Nat Med, 2020, 26(11): 1766-1775. DOI: 10.1038/s41591-020-1095-x .
[19]
Patrick DM, Sbihi H, Dai DLY, et al. Decreasing antibiotic use, the gut microbiota, and asthma incidence in children: evidence from population-based and prospective cohort studies[J]. Lancet Respir Med, 2020, 8(11): 1094-1105. DOI: 10.1016/S2213-2600(20)30052-7 .
[20]
Michalovich D, Rodriguez-Perez N, Smolinska S, et al. Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients[J]. Nat Commun, 2019, 10(1): 5711. PMCID: PMC6911092. DOI: 10.1038/s41467-019-13751-9 .
[21]
Martino C, Dilmore AH, Burcham ZM, et al. Microbiota succession throughout life from the cradle to the grave[J]. Nat Rev Microbiol, 2022, 20(12): 707-720. PMCID: PMC12875531. DOI: 10.1038/s41579-022-00768-z .
[22]
Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity[J]. Nat Rev Immunol, 2024, 24(8): 577-595. DOI: 10.1038/s41577-024-01014-8 .
[23]
Yu B, Pei C, Peng W, et al. Microbiota-derived butyrate alleviates asthma via inhibiting Tfh13-mediated IgE production[J]. Signal Transduct Target Ther, 2025, 10(1): 181. PMCID: PMC12141656. DOI: 10.1038/s41392-025-02263-2 .
[24]
Liang M, Li L, Fan J. Multi-target effects of short-chain fatty acids for obesity-related asthma: interventional potential and challenges[J]. Clin Rev Allergy Immunol, 2025, 68(1): 97. DOI: 10.1007/s12016-025-09100-y .
[25]
Stockinger B, Shah K, Wincent E. AHR in the intestinal microenvironment: safeguarding barrier function[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(8): 559-570. PMCID: PMC7611426. DOI: 10.1038/s41575-021-00430-8 .
[26]
Zhang ZY, Guo XL, Liu JT, et al. Conjugated bile acids alleviate acute pancreatitis through inhibition of TGR5 and NLRP3 mediated inflammation[J]. J Transl Med, 2024, 22(1): 1124. PMCID: PMC11662532. DOI: 10.1186/s12967-024-05922-0 .
[27]
Hammad H, Ahmed E, Lambrecht BN. Immunotherapy for asthma[J]. Cell Mol Immunol, 2025, 22(12): 1521-1532. PMCID: PMC12660796. DOI: 10.1038/s41423-025-01357-9 .
[28]
Chehimi M, Vidal H, Eljaafari A. Pathogenic role of IL-17: producing immune cells in obesity, and related inflammatory diseases[J]. J Clin Med, 2017, 6(7): 68. PMCID: PMC5532576. DOI: 10.3390/jcm6070068 .
[29]
Han S, Kim B, Hyeon DY, et al. Distinctive CD39+ CD9+ lung interstitial macrophages suppress IL-23/Th17-mediated neutrophilic asthma by inhibiting NETosis[J]. Nat Commun, 2024, 15(1): 8628. PMCID: PMC11452667. DOI: 10.1038/s41467-024-53038-2 .
[30]
Peters MC, Mcgrath KW, Hawkins GA, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts[J]. Lancet Respir Med, 2016, 4(7): 574-584. PMCID: PMC5007068. DOI: 10.1016/S2213-2600(16)30048-0 .
[31]
Sharma N, Akkoyunlu M, Rabin RL. Macrophages-common culprit in obesity and asthma[J]. Allergy, 2018, 73(6): 1196-1205. DOI: 10.1111/all.13369 .
[32]
Lei J, Shu Z, Zhu H, et al. AMPK regulates M1 macrophage polarization through the JAK2/STAT3 signaling pathway to attenuate airway inflammation in obesity-related asthma[J]. Inflammation, 2025, 48(1): 372-392. DOI: 10.1007/s10753-024-02070-x .
[33]
Calco GN, Maung JN, Jacoby DB, et al. Insulin increases sensory nerve density and reflex bronchoconstriction in obese mice[J]. JCI insight, 2022, 7(20): e161898. PMCID: PMC9714782. DOI: 10.1172/jci.insight.161898 .
[34]
Park YH, Oh EY, Han H, et al. Insulin resistance mediates high-fat diet-induced pulmonary fibrosis and airway hyperresponsiveness through the TGF-β1 pathway[J]. Exp Mol Med, 2019, 51(5): 1-12. PMCID: PMC6536500. DOI: 10.1038/s12276-019-0258-7 .
[35]
Hartsoe P, Holguin F, Chu HW. Mitochondrial dysfunction and metabolic reprogramming in obesity and asthma[J]. Int J Mol Sci, 2024, 25(5): 2944. PMCID: PMC10931700. DOI: 10.3390/ijms25052944 .
[36]
Cloonan SM, Kim K, Esteves P, et al. Mitochondrial dysfunction in lung ageing and disease[J]. Eur Respir Rev, 2020, 29(157): 200165. PMCID: PMC9488551. DOI: 10.1183/16000617.0165-2020 .
[37]
Stratakis N, Anguita-Ruiz A, Fabbri L, et al. Multi-omics architecture of childhood obesity and metabolic dysfunction uncovers biological pathways and prenatal determinants[J]. Nat Commun, 2025, 16(1): 654. PMCID: PMC11732992. DOI: 10.1038/s41467-025-56013-7 .
[38]
Wen S, Yuan G, Li C, et al. High cellulose dietary intake relieves asthma inflammation through the intestinal microbiome in a mouse model[J]. PLoS One, 2022, 17(3): e0263762. PMCID: PMC8912215. DOI: 10.1371/journal.pone.0263762 .
[39]
Lai Y, Qiu R, Zhou J, et al. Fecal microbiota transplantation alleviates airway inflammation in asthmatic rats by increasing the level of short-chain fatty acids in the intestine[J]. Inflammation, 2025, 48(3): 1538-1552. PMCID: PMC12234594. DOI: 10.1007/s10753-024-02233-w .
[40]
XIAO P, LI Y, LI X, et al. Long-term safety of fecal microbiota transplantation in chinese children from 2013 to 2023: a single-center retrospective study[J/OL]. BMC Microbiology, 2025, 25(1): 152. DOI:10.1186/s12866-025-03858-z .
[41]
Liu C, Zeng Z, Chen M, et al. Immunomodulatory roles of butyrate in asthma: mechanisms and therapeutic potentials[J]. Front Immunol, 2025, 16: 1639606. PMCID: PMC12375596. DOI: 10.3389/fimmu.2025.1639606 .
[42]
Korpela K, Salonen A, Vepsalainen O, et al. Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants[J]. Microbiome, 2018, 6(1): 182. PMCID: PMC6192119. DOI: 10.1186/s40168-018-0567-4 .
[43]
Guo Y, Shi J, Wang Q, et al. Metformin alleviates allergic airway inflammation and increases Treg cells in obese asthma[J]. J Cell Mol Med, 2021, 25(4): 2279-2284. PMCID: PMC7882927. DOI: 10.1111/jcmm.16269 .
[44]
Ma W, Jin Q, Guo H, et al. Metformin ameliorates inflammation and airway remodeling of experimental allergic asthma in mice by restoring AMPKα activity[J]. Front Pharmacol, 2022, 13: 780148. PMCID: PMC8830934. DOI: 10.3389/fphar.2022.780148 .
[45]
American Diabetes Association Professional Practice Committee for Diabetes. 14. Children and adolescents: standards of care in diabetes-2026[J]. Diabetes Care, 2026, 49(S1): S297-S320. PMCID: PMC12690182. DOI: 10.2337/dc26-S014 .
[46]
Kelly RS, Mendez KM, Huang M, et al. Metabo-endotypes of asthma reveal differences in lung function: discovery and validation in two TOPMed cohorts[J]. Am J Respir Crit Care Med, 2022, 205(3): 288-299. PMCID: PMC8886990. DOI: 10.1164/rccm.202105-1268OC .
[47]
Park YH, Fitzpatrick AM, Medriano CA, et al. High-resolution metabolomics to identify urine biomarkers in corticosteroid-resistant asthmatic children[J]. J Allergy Clin Immunol, 2017, 139(5): 1518-1524. DOI: 10.1016/j.jaci.2016.08.018 .

脚注

所有作者均声明无利益冲突。


PDF(755 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/